S&P 500   3,901.82
DOW   31,535.51
QQQ   323.67
S&P 500   3,901.82
DOW   31,535.51
QQQ   323.67
S&P 500   3,901.82
DOW   31,535.51
QQQ   323.67
S&P 500   3,901.82
DOW   31,535.51
QQQ   323.67
Log in
NASDAQ:CLBS

Caladrius Biosciences News Headlines

$1.90
-0.02 (-1.04 %)
(As of 03/2/2021 08:17 AM ET)
Add
Compare
Today's Range
$1.90
Now: $1.90
$1.90
50-Day Range
$1.55
MA: $2.10
$2.89
52-Week Range
$1.05
Now: $1.90
$4.89
Volume6 shs
Average Volume8.19 million shs
Market Capitalization$62.64 million
P/E RatioN/A
Dividend YieldN/A
Beta1.55

Headlines

Caladrius Biosciences (NASDAQ CLBS) News Headlines Today

Source:
SourceHeadline
Caladrius Biosciences, Inc. (CLBS) CEO David Mazzo on Q4 2020 Results - Earnings Call TranscriptCaladrius Biosciences, Inc. (CLBS) CEO David Mazzo on Q4 2020 Results - Earnings Call Transcript
seekingalpha.com - February 27 at 10:05 PM
Caladrius Biosciences (NASDAQ:CLBS) Announces  Earnings ResultsCaladrius Biosciences (NASDAQ:CLBS) Announces Earnings Results
americanbankingnews.com - February 26 at 8:43 PM
Caladrius Biosciences (NASDAQ:CLBS) Trading Down 9.9%Caladrius Biosciences (NASDAQ:CLBS) Trading Down 9.9%
americanbankingnews.com - February 25 at 9:40 PM
Caladrius Biosciences Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business UpdateCaladrius Biosciences Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update
finance.yahoo.com - February 25 at 7:01 PM
Caladrius Biosciences (NASDAQ:CLBS) Trading 13.4% Higher Caladrius Biosciences (NASDAQ:CLBS) Trading 13.4% Higher
americanbankingnews.com - February 24 at 7:20 PM
Caladrius Biosciences (CLBS) Scheduled to Post Quarterly Earnings on ThursdayCaladrius Biosciences (CLBS) Scheduled to Post Quarterly Earnings on Thursday
americanbankingnews.com - February 20 at 9:14 AM
Caladrius Biosciences (NASDAQ:CLBS)  Shares Down 7.6% Caladrius Biosciences (NASDAQ:CLBS) Shares Down 7.6%
americanbankingnews.com - February 18 at 8:34 PM
Caladrius Biosciences to Host Fourth Quarter and Full Year 2020 Financial Results Conference Call on Thursday, February 25, 2021 at 4:30 p.m. Eastern TimeCaladrius Biosciences to Host Fourth Quarter and Full Year 2020 Financial Results Conference Call on Thursday, February 25, 2021 at 4:30 p.m. Eastern Time
finance.yahoo.com - February 18 at 5:33 PM
Longeveron Inc. Announces the Appointment of Prominent Biotech, Capital Markets and Corporate Finance Executives to the Board of DirectorsLongeveron Inc. Announces the Appointment of Prominent Biotech, Capital Markets and Corporate Finance Executives to the Board of Directors
finance.yahoo.com - February 18 at 12:32 PM
Caladrius Biosciences (NASDAQ:CLBS)  Shares Down 14.7% Caladrius Biosciences (NASDAQ:CLBS) Shares Down 14.7%
americanbankingnews.com - February 12 at 8:20 PM
Caladrius Biosciences Sees Unusually High Options Volume (NASDAQ:CLBS)Caladrius Biosciences Sees Unusually High Options Volume (NASDAQ:CLBS)
americanbankingnews.com - February 12 at 11:32 AM
Caladrius Biosciences, Inc. Announces $65 Million Registered Direct Offerings Priced At-The-Market under Nasdaq RulesCaladrius Biosciences, Inc. Announces $65 Million Registered Direct Offerings Priced At-The-Market under Nasdaq Rules
finance.yahoo.com - February 12 at 9:04 AM
Caladrius Biosciences (NASDAQ:CLBS) Shares Up 16.7%Caladrius Biosciences (NASDAQ:CLBS) Shares Up 16.7%
americanbankingnews.com - February 11 at 7:34 PM
Caladrius Biosciences, Inc. (NASDAQ:CLBS) Short Interest UpdateCaladrius Biosciences, Inc. (NASDAQ:CLBS) Short Interest Update
americanbankingnews.com - February 11 at 7:18 AM
Caladrius Biosciences Closes $25.0 Million Private PlacementCaladrius Biosciences Closes $25.0 Million Private Placement
benzinga.com - January 25 at 5:29 PM
Caladrius Biosciences Announces Participation in Upcoming Virtual Conferences in February 2021Caladrius Biosciences Announces Participation in Upcoming Virtual Conferences in February 2021
finance.yahoo.com - January 25 at 11:42 AM
Caladrius Biosciences Announces $25.0 Million Private PlacementCaladrius Biosciences Announces $25.0 Million Private Placement
finance.yahoo.com - January 21 at 11:14 AM
Stock Alert: Caladrius Biosciences Hits New HighStock Alert: Caladrius Biosciences Hits New High
nasdaq.com - January 20 at 2:53 PM
Is Caladrius Stock a Buy Right Now? This Is What You Need to KnowIs Caladrius Stock a Buy Right Now? This Is What You Need to Know
finance.yahoo.com - January 20 at 2:53 PM
Caladrius Biosciences Treats First Patient in the Phase 2b FREEDOM Trial of CLBS16 for the Treatment of Coronary Microvascular DysfunctionCaladrius Biosciences Treats First Patient in the Phase 2b FREEDOM Trial of CLBS16 for the Treatment of Coronary Microvascular Dysfunction
finance.yahoo.com - January 19 at 4:05 PM
Caladrius Biosciences Announces Participation in Upcoming Virtual Investor Conferences in January 2021Caladrius Biosciences Announces Participation in Upcoming Virtual Investor Conferences in January 2021
finance.yahoo.com - January 6 at 10:04 AM
Caladrius Biosciences Provides Year-End 2020 Strategic Portfolio UpdateCaladrius Biosciences Provides Year-End 2020 Strategic Portfolio Update
benzinga.com - December 15 at 7:34 AM
Caladrius Biosciences to Present at the 13th Annual LD Micro Main Event ConferenceCaladrius Biosciences to Present at the 13th Annual LD Micro Main Event Conference
finance.yahoo.com - December 9 at 8:44 PM
Is Caladrius Biosciences Inc (CLBS) A Good Stock To Buy?Is Caladrius Biosciences Inc (CLBS) A Good Stock To Buy?
finance.yahoo.com - November 29 at 11:13 PM
Caladrius Biosciences Announces the Resignation of Dr. Douglas Losordo, Chief Medical OfficerCaladrius Biosciences Announces the Resignation of Dr. Douglas Losordo, Chief Medical Officer
finance.yahoo.com - November 17 at 7:41 PM
Caladrius Biosciences to Present at American Heart Association’s Virtual Scientific Sessions 2020Caladrius Biosciences to Present at American Heart Association’s Virtual Scientific Sessions 2020
finance.yahoo.com - November 10 at 8:57 AM
Caladrius Biosciences (CLBS) CEO David Mazzo on Q3 2020 Results - Earnings Call TranscriptCaladrius Biosciences' (CLBS) CEO David Mazzo on Q3 2020 Results - Earnings Call Transcript
seekingalpha.com - November 5 at 11:50 PM
Caladrius Biosciences EPS misses by $0.06Caladrius Biosciences EPS misses by $0.06
seekingalpha.com - November 5 at 6:49 PM
Caladrius Biosciences Provides Corporate Update and Reports 2020 Third Quarter Financial ResultsCaladrius Biosciences Provides Corporate Update and Reports 2020 Third Quarter Financial Results
finance.yahoo.com - November 5 at 6:49 PM
Caladrius Biosciences Announces Participation in Upcoming Virtual Investor Conferences in NovemberCaladrius Biosciences Announces Participation in Upcoming Virtual Investor Conferences in November
finance.yahoo.com - November 4 at 12:15 PM
Caladrius Biosciences to Host Third Quarter 2020 Financial Results Conference Call on Thursday, November 5, 2020 at 4:30 p.m. Eastern TimeCaladrius Biosciences to Host Third Quarter 2020 Financial Results Conference Call on Thursday, November 5, 2020 at 4:30 p.m. Eastern Time
finance.yahoo.com - October 29 at 9:28 AM
Caladrius Biosciences to Participate in the 8th Annual Chief Medical Officer Summit 360°Caladrius Biosciences to Participate in the 8th Annual Chief Medical Officer Summit 360°
finance.yahoo.com - October 21 at 9:14 AM
Caladrius Bio launches CLBS119 study to repair COVID-19-induced lung damageCaladrius Bio launches CLBS119 study to repair COVID-19-induced lung damage
seekingalpha.com - October 8 at 9:44 AM
Caladrius Biosciences to Participate in Landmark’s 10th Annual Investing for Cures Virtual ForumCaladrius Biosciences to Participate in Landmark’s 10th Annual Investing for Cures Virtual Forum
finance.yahoo.com - September 10 at 12:12 PM
Caladrius Biosciences Announces Registration of HONEDRA® Trademark and New Patent in JapanCaladrius Biosciences Announces Registration of HONEDRA® Trademark and New Patent in Japan
finance.yahoo.com - September 9 at 9:25 AM
Caladrius Biosciences to Present at H.C. Wainwright 22nd Annual Global Investment Virtual ConferenceCaladrius Biosciences to Present at H.C. Wainwright 22nd Annual Global Investment Virtual Conference
finance.yahoo.com - September 8 at 8:23 AM
Caladrius Biosciences to Participate in the Advanced Therapies Congress & Expo 2020Caladrius Biosciences to Participate in the Advanced Therapies Congress & Expo 2020
finance.yahoo.com - September 3 at 12:09 PM
Caladrius Biosciences to Present at the LD 500 Virtual Conference on September 1, 2020 at 11:40 AM Eastern TimeCaladrius Biosciences to Present at the LD 500 Virtual Conference on September 1, 2020 at 11:40 AM Eastern Time
finance.yahoo.com - August 27 at 1:01 PM
Caladrius Biosciences, Inc. Common Stock (CLBS)Caladrius Biosciences, Inc. Common Stock (CLBS)
nasdaq.com - August 20 at 8:16 AM
Caladrius Biosciences (CLBS) CEO David Mazzo on Q2 2020 Results - Earnings Call TranscriptCaladrius Biosciences' (CLBS) CEO David Mazzo on Q2 2020 Results - Earnings Call Transcript
seekingalpha.com - August 14 at 1:16 AM
Caladrius Biosciences +9% on surprise earnings beatCaladrius Biosciences +9% on surprise earnings beat
seekingalpha.com - August 13 at 8:16 PM
Caladrius Biosciences Provides Corporate Update and Reports 2020 Second Quarter Financial ResultsCaladrius Biosciences Provides Corporate Update and Reports 2020 Second Quarter Financial Results
finance.yahoo.com - August 13 at 8:16 PM
Caladrius Biosciences to Host Second Quarter 2020 Financial Results Conference Call on Thursday, August 13, 2020Caladrius Biosciences to Host Second Quarter 2020 Financial Results Conference Call on Thursday, August 13, 2020
finance.yahoo.com - August 6 at 9:22 AM
Caladrius Biosciences Announces the Resignation of Joseph Talamo, Chief Financial OfficerCaladrius Biosciences Announces the Resignation of Joseph Talamo, Chief Financial Officer
finance.yahoo.com - August 5 at 6:20 PM
Caladrius Biosciences Appoints Dr. Michael H. Davidson to Board of DirectorsCaladrius Biosciences Appoints Dr. Michael H. Davidson to Board of Directors
finance.yahoo.com - July 29 at 11:14 PM
Caladrius Biosciences Appoints Dr. Michael H. Davidson to Board of DirectorsCaladrius Biosciences Appoints Dr. Michael H. Davidson to Board of Directors
finance.yahoo.com - July 28 at 10:13 AM
Implied Volatility Surging for Caladrius Biosciences (CLBS) Stock OptionsImplied Volatility Surging for Caladrius Biosciences (CLBS) Stock Options
www.nasdaq.com - July 15 at 9:34 AM
Caladrius Biosciences to Present on CLBS119 for COVID-19 Induced Lung Damage at the BioNJ COVID-19 Rapid Fire Research ShowcaseCaladrius Biosciences to Present on CLBS119 for COVID-19 Induced Lung Damage at the BioNJ COVID-19 Rapid Fire Research Showcase
finance.yahoo.com - June 2 at 12:36 PM
Caladrius Biosciences Closes $4.3 Million Registered Direct Offering Priced At-The-Market under Nasdaq RulesCaladrius Biosciences Closes $4.3 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
finance.yahoo.com - May 28 at 2:28 PM
Caladrius Bio slips 18% on launch of $4.3M direct offeringCaladrius Bio slips 18% on launch of $4.3M direct offering
seekingalpha.com - May 26 at 9:07 AM
This page was last updated on 3/2/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.